Zinc in ulcerative colitis: a therapeutic trial and report on plasma levels.
- 1 January 1977
- Vol. 18 (1) , 33-36
- https://doi.org/10.1136/gut.18.1.33
Abstract
A double-blind controlled trial of oral zinc sulfate as adjuvant treatment in idiopathic ulcerative colitis or proctitis in relapse is reported. Patients (51) were treated, and the clinical and sigmoidoscopic improvement in the Zn treated patients was similar to that in patients receiving placebo. No difference was found between plasma Zn levels in a further 46 patients with idiopathic ulcerative colitis or proctitis and those obtained in a group of healthy controls.This publication has 15 references indexed in Scilit:
- ACRODERMATITIS ENTEROPATHICA: A LETHAL INHERITED HUMAN ZINC-DEFICIENCY DISORDERThe Lancet, 1974
- ZINC DEFICIENCY WITH ALTERED ADRENOCORTICAL FUNCTION AND ITS RELATION TO DELAYED HEALINGThe Lancet, 1973
- Clinical trial of a new carbenoxolone analogue (BX24), zinc sulphate, and vitamin A in the treatment of gastric ulcerGut, 1972
- EFFECTS OF LONG-CONTINUED INGESTION OF ZINC SULPHATE IN PATIENTS WITH VENOUS LEG ULCERATIONThe Lancet, 1970
- ORAL ZINC SULPHATE IN SICKLE-CELL ULCERSThe Lancet, 1970
- PLASMA-ZINC IN HEALTH AND DISEASEThe Lancet, 1970
- ORAL ZINC SULPHATE IN LEG ULCERSThe Lancet, 1969
- ACCELERATION OF WOUND HEALING IN MAN WITH ZINC SULPHATE GIVEN BY MOUTHThe Lancet, 1967
- SULPHASALAZINE AND SALICYLAZOSULPHADIMIDINE IN ULCERATIVE COLITISThe Lancet, 1962
- Cortisone in Ulcerative ColitisBMJ, 1955